Organon & Co.
US ˙ NYSE

SecurityOGN / Organon & Co.
InstitutionLindbrook Capital, Llc
Latest Disclosed Ownership2,096 shares
Latest Disclosed Value $ 31,209
Lindbrook Capital, Llc reports 1.73% decrease in ownership of OGN / Organon & Co.

On May 5, 2025 - Lindbrook Capital, Llc filed a 13F-HR form disclosing ownership of 2,096 shares of Organon & Co. (US:OGN) valued at $31,209 USD as of March 31, 2025. The entity filed a previous 13F-HR on February 6, 2025 disclosing 2,133 shares of Organon & Co.. This represents a change in shares of -1.73% during the quarter. The current value of the position is $28,003 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-05-05 2025-03-31 13F ORGANON & CO Stock 68622V106 2,096 -37 -1.73 31 0.00 0.0029
2025-02-06 2024-12-31 13F ORGANON & CO Stock 68622V106 2,133 -647 -23.27 32 -41.51 0.0029
2024-11-01 2024-09-30 13F ORGANON & CO Stock 68622V106 2,780 -426 -13.29 53 -19.70 0.0047
2024-07-31 2024-06-30 13F ORGANON & CO Stock 68622V106 3,206 1,106 52.67 66 69.23 0.0062
2024-04-25 2024-03-31 13F ORGANON & CO Stock 68622V106 2,100 262 14.25 39 50.00 0.0037
2024-02-01 2023-12-31 13F ORGANON & CO Stock 68622V106 1,838 1,428 348.29 27 271.43 0.0026
2023-10-25 2023-09-30 13F ORGANON & CO Stock 68622V106 410 -92 -18.33 7 -30.00 0.0008
2023-07-31 2023-06-30 13F ORGANON & CO Stock 68622V106 502 -436 -46.48 10 -54.55 0.0011
2023-04-26 2023-03-31 13F ORGANON & CO Stock 68622V106 938 429 84.28 22 57.14 0.0026
2023-01-25 2022-12-31 13F ORGANON & CO Stock 68622V106 509 -71 -12.24 14 0.00 0.0018
2022-11-10 2022-09-30 13F ORGANON & CO Stock 68622V106 580 -167 -22.36 14 -44.00 0.0024
2022-08-01 2022-06-30 13F ORGANON & CO Stock 68622V106 747 19 2.61 25 0.00 0.0041
2022-04-21 2022-03-31 13F ORGANON & CO Stock 68622V106 728 257 54.56 25 78.57 0.0039
2022-01-18 2021-12-31 13F ORGANON & CO Stock 68622V106 471 57 13.77 14 0.00 0.0021
2021-11-05 2021-09-30 13F ORGANON & CO Stock 68622V106 414 -82 -16.53 14 -6.67 0.0037
2021-07-27 2021-06-30 13F ORGANON & CO Stock 68622V106 496 496 15 0.0034
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.